Ulcerative Colitis Newswire (Page 9)

Ulcerative Colitis Newswire (Page 9)

Comprehensive Real-Time News Feed for Ulcerative Colitis. (Page 9)

Results 161 - 180 of 3,583 in Ulcerative Colitis

  1. Seres Therapeutics Announces Appointment of Eric D. Shaff to...Read the original story

    Jan 31, 2018 | Customer Interaction Solutions

    ... matured, and now includes the SER-109 Phase 3 program for recurrent C. difficile infection, SER-287 for ulcerative colitis, and SER-262 for primary C. difficile infection, as well as several preclinical stage programs, including SER-401 to enhanc ...

    Comment?

  2. Three generation of same family sign up for OX5 Run for Oxford Children's HospitalRead the original story w/Photo

    Jan 31, 2018 | Oxford Mail

    THREE generations of the same family will take on the OX5 Run to say thank you and raise money for Oxford Children's Hospital. Ten-year-old Megan Ferguson was diagnosed with ulcerative colitis - a condition in which the colon and rectum become inflamed - in January last year.

    Comment?

  3. Arena Pharmaceuticals (ARNA) Earning Somewhat Positive Media Coverage, Analysis FindsRead the original story w/Photo

    Jan 31, 2018 | IntersportsWire

    ... has three primary investigational clinical programs: etrasimod (APD334) in Phase II evaluation for ulcerative colitis, APD371 entering Phase II evaluation for the treatment of pain associated with Crohn's disease, and ralinepag (APD811) in Phase II ...

    Comment?

  4. Pfizer's (PFE) CEO Ian Read on Q4 2017 Results - Earnings Call TranscriptRead the original story w/Photo

    Jan 30, 2018 | Seeking Alpha

    ... s for psoriatic arthritis, and we are hopeful that we will receive U.S. approval for a further indication ulcerative colitis this year. Chantix revenue grew 18% operationally to nearly $1 billion for the year. Lyrica revenues within [ph] Pfizer's ...

    Comment?

  5. Medical education systematically ignores the diversity of medical practiceRead the original story w/Photo

    Jan 30, 2018 | Kevin, M.D.

    ... as a way to make sense of the vast world of medical complexity. We memorize key associations, like ulcerative colitis and primary sclerosing cholangitis. These connections are helpful memorization tools, but can also be undermined by the complexity ...

    Comment?

  6. PIPs: 'I had to give back my Motability vehicle'Read the original story w/Photo

    Jan 30, 2018 | BBC News

    ... act a change to their claims could have on their lives. Vicky Smith lives in Newcastle upon Tyne. She has ulcerative colitis and wears a stoma. Dealing with excruciating pain on a daily basis, means that she's sometimes bedridden.

    Comment?

  7. Ostomy Care Accessories Market 2023: By Product, Application,...Read the original story

    Jan 30, 2018 | SBWire

    ... for surgery, while it is a temporary solution for other medical conditions. Ostomy is useful in even ulcerative colitis condition to remove liquid stool from the small intestine by attaching a rectal pouch. Adhesives, belts, cleanser, convex insert, ...

    Comment?

  8. Innovate Biopharmaceuticals Announces Successful Merger CompletionRead the original story

    Jan 30, 2018 | Customer Interaction Solutions

    ... we will be able to engage a wider range of investors, which will allow us to advance our mild-to-moderate ulcerative colitis combination therapy into Phase 2 trials and to expand our pipeline." Jay Madan, founder and president, of Innovate remarked, ...

    Comment?

  9. IBS vs. IBD: Signs, Symptoms, and Causes of EachRead the original story w/Photo

    Jan 29, 2018 | Self.com

    ... to happen when a person's immune system accidentally attacks their GI tract, according to the NIDDK. Ulcerative colitis and Crohn's disease are mysterious, but they do share a few risk factors. Both conditions tend to run in families, so researchers ...

    Comment?

  10. Protagonist Therapeutics 'Poised For Upside,' Stifel SaysRead the original story w/Photo

    Jan 29, 2018 | Benzinga

    ... committee is expected to recommend continuation of PTG-100 phase 2b trials in moderate-to-severe ulcerative colitis, the results of which will be released in the fourth quarter, Walsh said. The analyst said he anticipates both regulatory support and ...

    Comment?

  11. AbbVie to Award Shareholders, Increase Employees' Pay on Rosy 2018 ForecastRead the original story w/Photo

    Jan 28, 2018 | BioSpace

    AbbVie manufactures and markets the world's best-selling drug, Humira, for arthritis, plaque psoriasis, ankylosing spondylitis, Crohn's disease, and ulcerative colitis, as well as other drugs. The company indicates that its tax rate for 2018 will be 9 percent, significantly lower than the expected 20 percent.

    Comment?

  12. Phivida Launches Nano-CBD Iced Tea Product LineRead the original story

    Jan 29, 2018 | Newkerala.com

    ... CBD is widely studied on Inflammatory Bowel Disease (IBD) a chronic inflammatory condition comprised of; Ulcerative Colitis (UC) and Crohn's disease (CD), as illustrated on www.pubmed.gov. A 2014 report from Crohn's & Colitis Foundation of America ...

    Comment?

  13. Synlogic: Precision-Programmed Probiotics To Treat Human DiseaseRead the original story w/Photo

    Jan 29, 2018 | Seeking Alpha

    ... for inflammatory bowel disease (IBD). The collaboration will mainly focus on treating Crohn's disease and ulcerative colitis. JosA -Carlos GutiA rrez-Ramos, CEO of Synlogic: This partnership with AbbVie is a part of our overall strategy ...

    Comment?

  14. Analysts at Canaccord Genuity Kept their Buy rating for Synergy...Read the original story w/Photo

    Jan 29, 2018 | Hill Country Times

    ... It currently has negative earnings. The firm also develops dolcanatide to treat mild-to-moderate ulcerative colitis. Analysts await Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) to report earnings on March, 7. They expect $-0.20 EPS, up 35.48% or $0.11 ...

    Comment?

  15. Bodybuilder and fitness model Zoey Wright fundraising for K9 CrusadersRead the original story w/Photo

    Jan 29, 2018 | Falmouth Packet

    ... campus, donations can be made online at totalgiving.co.uk/MYpage/zoey. In 2012 Zoey was diagnosed with ulcerative colitis, a form of inflammatory bowel disease and an incurable condition, which saw her in and out of hospital for two years. She then ...

    Comment?

  16. The biological clock as an ally in the fight against inflammatory diseaseRead the original story w/Photo

    Jan 29, 2018 | PhysOrg Weblog

    ... to trigger acute hepatitis. Sometimes ... Inflammatory bowel disease (IBD), including the two conditions ulcerative colitis and Crohn's disease, results in long-term inflammation of the gut and is associated with dysregulation of the immune system. ...

    Comment?

  17. Monster Digital and Innovate Biopharmaceuticals Extend Outside Closing Date for MergerRead the original story w/Photo

    Jan 29, 2018 | GlobeNewswire

    ... including celiac disease, irritable bowel syndrome (IBS), inflammatory bowel diseases (IBD, Crohn's and ulcerative colitis), type 1 diabetes mellitus (T1DM), nonalcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and several others. Some ...

    Comment?

  18. Epidemiology of gastrointestinal symptoms in young and middle-aged...Read the original story w/Photo

    Jan 26, 2018 | BioMed Central

    ... that many chronic conditions are associated with psychological disorders. It is worth noting that ulcerative colitis was interpreted by psychosomatic theory until the discovery of immune dysregulation [ In general, causal relationships are hard to ...

    Comment?

  19. Remicade Biosimilar Market Projected to Grow Steadily During 2016-2026 by FMI ShareRead the original story w/Photo

    Jan 26, 2018 | SBWire

    ... disease in both adult and pediatric patients. Additionally it is also used for treatment of active ulcerative colitis, moderate to severe rheumatoid arthritis in combination with methroxate, spinal and active psoriatic arthritis, and plaque ...

    Comment?

  20. Weekly Investment Analysts' Ratings Updates for Arena PharmaceuticalsRead the original story w/Photo

    Jan 26, 2018 | IntersportsWire

    ... has three primary investigational clinical programs: etrasimod (APD334) in Phase II evaluation for ulcerative colitis, APD371 entering Phase II evaluation for the treatment of pain associated with Crohn's disease, and ralinepag (APD811) in Phase II ...

    Comment?